ATX 4.69% 6.1¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-5

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    Not quite as bad as that. Median survival (at least from the recent chemo trials) is 9-11 months depending on the chemo type used.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.